Israel-based biotechnology company Polypid Ltd. has raised $15 million from both shareholders and new investors.

The investment was made to a pre-funding company valuation of $180 million.

The company has raised a total of $53.8 million in six funding rounds.

On November 10, 2016, Polypid closed $5.3 million in its venture round.